Autopsy report · NCT01709396
ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS
Cause of deathFutility, also staffing, sites or logistics
“initial on hold due to space but now permanently suspended due to futility.”
Life of this trial
- Registered 9 months after it had already started.
- Suspended: paused, and may or may not restart.
- 20 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 2
- Sponsor
- Ottawa Hospital Research Institute
- Sponsor type
- University, hospital or other
- Conditions
- Acute Leukemia; Myelodysplastic Syndrome
- Interventions
- ED-TBI
- Participants
- 20 (planned, not actual)
- Sites
- 1
- Countries
- Canada
Trials that died the same way
- Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis
“Suspended due to lack of funding.” - Low-Intensity Focused Ultrasound Neuromodulation of the Mediodorsal Thalamus for Treatment-Resistant Schizophrenia
“Indefinite hold due to administrative issues.” - Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
“closed due to futility”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.